Results for transaminasi translation from Maltese to English

transaminasi
increased

- transaminasi elevati
- transaminases elevations

śieda fit- transaminasi
transaminases increased

Żieda tas- serum transaminasi:
increased serum transaminases:

komuni ħafna Żieda tat-transaminasi
very common transaminases increased

[ transaminasi > uln u/jew ggt > 5uln ],
[ transaminases > uln and/or ggt > 5uln ].

transaminasi għoljin, qt wiesa’ fl-elettrokardjogramm
elevated transaminases-, electrocardiogram qt

Żieda tal-analina amino transaminasi (alt)
alanine amino transaminase (alt) increased

kienu rrappurtati żidiet fit-transaminasi tal-fwied.
elevations of liver transaminases have been reported.

transaminasi elevati grad 3 kien irrapportat f’24% tal-pazjenti.
grade 3 elevated transaminases were reported in 24% of patients.

rari kienu osservati żidiet tat-transaminasi f’pazjenti bil-caps.
elevations of transaminases have been observed rarely in caps patients.

għal transaminasi tal-grad 2 jew żieda fil-bilirubina totali, nivolumab għandu jitwaqqaf.
for grade 2 transaminase or total bilirubin elevation, nivolumab should be withheld.

riżultati mhux normali tal-funzjoni tal-fwied (żieda fit-transaminasi).
abnormal liver function test results (transaminases increased).

għal transaminasi tal-grad 2 jew żieda fil-bilirubina totali, nivolumab jew nivolumab mogħti flimkien ma’ ipilimumab għandhom jitwaqqfu.
for grade 2 transaminase or total bilirubin elevation, nivolumab or nivolumab in combination with ipilimumab should be withheld.

il-pazjenti għandhom jiġu mmonitorjati għal sinjali u sintomi ta’ epatite bħal żieda fit-transaminasi u fil-bilirubina totali.
patients should be monitored for signs and symptoms of hepatitis such as transaminase and total bilirubin elevations.

kull pazjent li jiżviluppa żieda fis- serum transaminasi għandu jkollu jirrepeti t- testijiet tal- funzjoni tal- fwied fi żmien 48 siegħa.
3 increased serum transaminases should have his/ her liver function tests repeated within 48 hours.

provi kliniċi rrappurtaw każijiet momentarji u asintomatiċi ta’ żidiet tat-transaminasi jew tal-bilirubin (ara sezzjoni 4.8).
transient and asymptomatic cases of elevations of serum transaminases or bilirubin have been reported in clinical trials (see section 4.8).

it-tossiċitajiet osservati f’dawn il-pazjenti kienu jinkludu rramettar, iperbilirubinemja, u livelli elevati ta’ transaminasi u raxx makulo-papulari.
the toxicities observed in these patients included vomiting, hyperbilirubinaemia, elevated transaminase levels and maculo-papular rash.